Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.85%
#4 aPriori aPriori +110.10%
#5 Bedrock Bedrock +74.70%
#6 Cysic Cysic +48.18%
#7 Prom Prom +39.78%
#8 Playnance Playnance +35.10%
#9 COTI COTI +28.56%
#10 Nillion Nillion +23.46%
Coin of the day
Wrapped One Wrapped One
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Rang in aandelen #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Aandeelprijs
$0.0009
Laatst gesynchroniseerd: 2025-05-27
Marktkapitalisatie
$1.15K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Arch Therapeutics, Inc. (ARTH)

Categorie

Healthcare
P/B-ratio voor Arch Therapeutics, Inc. (ARTH)
P/B-ratio op August 2026 TTM: 0.00
Volgens de meest recente financiële rapporten en aandelenkoers van Arch Therapeutics, Inc. is de huidige P/B-ratio (TTM) 0.00. Eind 2022 had het bedrijf een P/B-ratio van -1.10.
P/B-ratiohistoriek voor Arch Therapeutics, Inc. van 2011 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 0.00 -100.00%
2023 -0.53 -51.55%
2022 -1.10 -96.06%
2021 -27.88 -99.36%
2020 -4.34K -56.09%
2019 -9.89K -210.08%
2018 8.98K -13.48%
2017 10.38K 98.71%
2016 5.23K 86.57%
2015 2.80K -894.57%
2014 -352.52 -102.95%
2013 11.96K -115.55%
2012 -76.90K -630.43%
2011 14.50K 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR